Business
Press Release Dec 11 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 11, 2023, titled "Zydus andDaewoong Pharmaceutical announce exclusive licensing agreement for development andcommercialization of Leuprolide Long-Acting Injectable in the U.S.".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated December 11, 2023, titled \"Zydus andDaewoong Pharmaceutical announce exclusive licensing agreement for development andcommercialization of Leuprolide Long-Acting Injectable in the U.S.\". View Attachment","length":425,"tagName":"div"}]